chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Constipation, Diarrhoea, Pain in extremity
Clinical narrative: diarrhea (from laxative taken today); constipation; sore arm for a few days (left); This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea (from laxative taken today)), CONSTIPATION (constipation) and PAIN IN EXTREMITY (sore arm for a few days (left)) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL, CLOPIDOGREL BISULFATE (PLAVIX), AMLODIPINE, LOSARTAN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and ATORVASTATIN for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm for a few days (left)). On 08-May-2021, the patient experienced CONSTIPATION (constipation). On 10-May-2021, the patient experienced DIARRHOEA (diarrhea (from laxative taken today)). The patient was treated with BISACODYL (LAXATIVE [BISACODYL]) on 10-May-2021 for Constipation, at an unspecified dose and frequency. On 17-Apr-2021, PAIN IN EXTREMITY (sore arm for a few days (left)) had resolved. On 10-May-2021, CONSTIPATION (constipation) had resolved. At the time of the report, DIARRHOEA (diarrhea (from laxative taken today)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments.  Reporter stated that patient will reschedule the vaccine as soon as possible.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Off label use
Clinical narrative: the patient was recoviering from Covid19; Second schedualed >36 after the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (the patient was recoviering from Covid19) and OFF LABEL USE (Second schedualed >36 after the first dose) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2021, the patient experienced OFF LABEL USE (Second schedualed >36 after the first dose). On an unknown date, the patient experienced COVID-19 (the patient was recoviering from Covid19). On 11-May-2021, OFF LABEL USE (Second schedualed >36 after the first dose) had resolved. At the time of the report, COVID-19 (the patient was recoviering from Covid19) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications and treatment information was not provided.  Second dose was delayed since the patient was recovering from Covid19.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dyspnoea, Headache, Myalgia, Weight decreased
Clinical narrative: anxiety; trouble breathing; weight loss; and the upper part of her body is really achy; its effecting my brain; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (anxiety), DYSPNOEA (trouble breathing), WEIGHT DECREASED (weight loss), MYALGIA (and the upper part of her body is really achy) and HEADACHE (its effecting my brain) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (oesophageal) and Allergy multiple.   On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (anxiety), DYSPNOEA (trouble breathing), WEIGHT DECREASED (weight loss), MYALGIA (and the upper part of her body is really achy) and HEADACHE (its effecting my brain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ANXIETY (anxiety), DYSPNOEA (trouble breathing), WEIGHT DECREASED (weight loss), MYALGIA (and the upper part of her body is really achy) and HEADACHE (its effecting my brain) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant medication included four allergy medications, acid reflux medication and anxiety medications.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm, with a little pain for 12 hours; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm, with a little pain for 12 hours) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm, with a little pain for 12 hours). On 21-Mar-2021, PAIN IN EXTREMITY (sore arm, with a little pain for 12 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications provided.. No treatment medications provided   This case was linked to MOD-2021-118385 (Patient Link).
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Dyspnoea, Heart rate increased, Myalgia
Clinical narrative: Extremely dizzy; Elevated heart rate; Some trouble breathing; Body aches; Joint pain; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Extremely dizzy), HEART RATE INCREASED (Elevated heart rate), DYSPNOEA (Some trouble breathing), MYALGIA (Body aches) and ARTHRALGIA (Joint pain) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced DIZZINESS (Extremely dizzy), HEART RATE INCREASED (Elevated heart rate), DYSPNOEA (Some trouble breathing), MYALGIA (Body aches), ARTHRALGIA (Joint pain) and NAUSEA (nausea). At the time of the report, DIZZINESS (Extremely dizzy), HEART RATE INCREASED (Elevated heart rate), DYSPNOEA (Some trouble breathing), MYALGIA (Body aches), ARTHRALGIA (Joint pain) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Extremely dizzy; Elevated heart rate; Some trouble breathing; Body aches; Joint pain; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Extremely dizzy), HEART RATE INCREASED (Elevated heart rate), DYSPNOEA (Some trouble breathing), MYALGIA (Body aches) and ARTHRALGIA (Joint pain) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced DIZZINESS (Extremely dizzy), HEART RATE INCREASED (Elevated heart rate), DYSPNOEA (Some trouble breathing), MYALGIA (Body aches), ARTHRALGIA (Joint pain) and NAUSEA (nausea). At the time of the report, DIZZINESS (Extremely dizzy), HEART RATE INCREASED (Elevated heart rate), DYSPNOEA (Some trouble breathing), MYALGIA (Body aches), ARTHRALGIA (Joint pain) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Myalgia, Nausea, Pyrexia
Clinical narrative: chills; she developed fever which goes as high as 103 degree; body aches; nauseous; She was down for days; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (she developed fever which goes as high as 103 degree), MYALGIA (body aches), NAUSEA (nauseous) and FEELING ABNORMAL (She was down for days) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced CHILLS (chills), NAUSEA (nauseous) and VACCINATION SITE ERYTHEMA (injection site redness). On an unknown date, the patient experienced PYREXIA (she developed fever which goes as high as 103 degree), MYALGIA (body aches) and FEELING ABNORMAL (She was down for days). At the time of the report, CHILLS (chills), NAUSEA (nauseous) and VACCINATION SITE ERYTHEMA (injection site redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: chills; she developed fever which goes as high as 103 degree; body aches; nauseous; She was down for days; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (she developed fever which goes as high as 103 degree), MYALGIA (body aches), NAUSEA (nauseous) and FEELING ABNORMAL (She was down for days) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced CHILLS (chills), NAUSEA (nauseous) and VACCINATION SITE ERYTHEMA (injection site redness). On an unknown date, the patient experienced PYREXIA (she developed fever which goes as high as 103 degree), MYALGIA (body aches) and FEELING ABNORMAL (She was down for days). At the time of the report, CHILLS (chills), NAUSEA (nauseous) and VACCINATION SITE ERYTHEMA (injection site redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: Patient strongly believe, that patient did not receive the vaccine intramuscularly."Vaccine was given in my arm, but not in to my muscle".; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient strongly believe, that patient did not receive the vaccine intramuscularly."Vaccine was given in my arm, but not in to my muscle".) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient strongly believe, that patient did not receive the vaccine intramuscularly."Vaccine was given in my arm, but not in to my muscle".). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient strongly believe, that patient did not receive the vaccine intramuscularly."Vaccine was given in my arm, but not in to my muscle".) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment details were provided
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Interchange of vaccine products
Clinical narrative: a patient was given Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna covid-19 vaccine; Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (a patient was given Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna covid-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (a patient was given Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna covid-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (a patient was given Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna covid-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: It was like someone turned the ringing/buzzing up in his right ear, the sound as the high pitch ringing like from a fax machine; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (It was like someone turned the ringing/buzzing up in his right ear, the sound as the high pitch ringing like from a fax machine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced TINNITUS (It was like someone turned the ringing/buzzing up in his right ear, the sound as the high pitch ringing like from a fax machine). At the time of the report, TINNITUS (It was like someone turned the ringing/buzzing up in his right ear, the sound as the high pitch ringing like from a fax machine) had not resolved.            No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.  The patient stated that the symptoms increased after the second dose.   This case was linked to MOD-2021-118049 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy, Myalgia
Clinical narrative: Neck pain; Tiredness; shivering; underlining headache constantly; the glands in neck is swollen; Ache NOS; Tenderness NOS; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Ache NOS), TENDERNESS (Tenderness NOS), NECK PAIN (Neck pain), FATIGUE (Tiredness) and CHILLS (shivering) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMINS NOS for an unknown indication.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced MYALGIA (Ache NOS), TENDERNESS (Tenderness NOS), FATIGUE (Tiredness), CHILLS (shivering), HEADACHE (underlining headache constantly) and LYMPHADENOPATHY (the glands in neck is swollen). On an unknown date, the patient experienced NECK PAIN (Neck pain). At the time of the report, MYALGIA (Ache NOS), TENDERNESS (Tenderness NOS), NECK PAIN (Neck pain), FATIGUE (Tiredness), CHILLS (shivering), HEADACHE (underlining headache constantly) and LYMPHADENOPATHY (the glands in neck is swollen) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable No treatment medication were reported.    This case was linked to MOD-2021-118409.
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Tenderness
Clinical narrative: Neck pain; Tiredness; shivering; underlining headache constantly; the glands in neck is swollen; Ache NOS; Tenderness NOS; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Ache NOS), TENDERNESS (Tenderness NOS), NECK PAIN (Neck pain), FATIGUE (Tiredness) and CHILLS (shivering) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMINS NOS for an unknown indication.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced MYALGIA (Ache NOS), TENDERNESS (Tenderness NOS), FATIGUE (Tiredness), CHILLS (shivering), HEADACHE (underlining headache constantly) and LYMPHADENOPATHY (the glands in neck is swollen). On an unknown date, the patient experienced NECK PAIN (Neck pain). At the time of the report, MYALGIA (Ache NOS), TENDERNESS (Tenderness NOS), NECK PAIN (Neck pain), FATIGUE (Tiredness), CHILLS (shivering), HEADACHE (underlining headache constantly) and LYMPHADENOPATHY (the glands in neck is swollen) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable No treatment medication were reported.    This case was linked to MOD-2021-118409.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: very sore arm and can't lift it; very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (very sore arm and can't lift it) and PAIN IN EXTREMITY (very sore arm) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (very sore arm and can't lift it) and PAIN IN EXTREMITY (very sore arm). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (very sore arm and can't lift it) and PAIN IN EXTREMITY (very sore arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. Treatment included ice packs.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Did not receive 2nd dose of Vaccine 43 days of 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Did not receive 2nd dose of Vaccine 43 days of 1st dose) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not receive 2nd dose of Vaccine 43 days of 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Did not receive 2nd dose of Vaccine 43 days of 1st dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not reported.  Treatment medication not reported.
Age: 65.0
Sex: U
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Not feeling well post second dose of Moderna COVID-19 Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well post second dose of Moderna COVID-19 Vaccine) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 UNK. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Not feeling well post second dose of Moderna COVID-19 Vaccine). At the time of the report, MALAISE (Not feeling well post second dose of Moderna COVID-19 Vaccine) outcome was unknown.            no concomitant medications were provided by the reporter
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia, Rash, Urticaria, Vaccination site erythema
Clinical narrative: Welts; Red bumps; Rash, stomach,neck and back; fever; flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), URTICARIA (Welts), VACCINATION SITE ERYTHEMA (Red bumps), RASH (Rash, stomach,neck and back) and PYREXIA (fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DIAZEPAM, LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and OMEPRAZOLE for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms) and PYREXIA (fever). On 02-Apr-2021, the patient experienced URTICARIA (Welts), VACCINATION SITE ERYTHEMA (Red bumps) and RASH (Rash, stomach,neck and back). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), URTICARIA (Welts), VACCINATION SITE ERYTHEMA (Red bumps), RASH (Rash, stomach,neck and back) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: Developed another Fever of 100.9 Fahrenheit; Developed a fever 102.8 Fahrenheit; Chest pain in the middle of sternum radiating out; Chills; Could not get out of bed; No appetite; Severe Headache; Body hurt when you touch the skin; At 7pm developed a headache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), CHEST PAIN (Chest pain in the middle of sternum radiating out), HEADACHE (At 7pm developed a headache), CHILLS (Chills) and FATIGUE (Could not get out of bed) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (At 7pm developed a headache). On 07-May-2021, the patient experienced DECREASED APPETITE (No appetite), CHILLS (Chills), FATIGUE (Could not get out of bed), HEADACHE (Severe Headache) and MYALGIA (Body hurt when you touch the skin). On 08-May-2021, the patient experienced CHEST PAIN (Chest pain in the middle of sternum radiating out) and PYREXIA (Developed a fever 102.8 Fahrenheit). On 10-May-2021, the patient experienced PYREXIA (Developed another Fever of 100.9 Fahrenheit). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 milligram and IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 200 milligram. On 07-May-2021, HEADACHE (At 7pm developed a headache) had resolved. On 09-May-2021, CHEST PAIN (Chest pain in the middle of sternum radiating out) and PYREXIA (Developed a fever 102.8 Fahrenheit) had resolved. At the time of the report, DECREASED APPETITE (No appetite), CHILLS (Chills), FATIGUE (Could not get out of bed), PYREXIA (Developed another Fever of 100.9 Fahrenheit), HEADACHE (Severe Headache) and MYALGIA (Body hurt when you touch the skin) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-118157 (Patient Link).
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Developed another Fever of 100.9 Fahrenheit; Developed a fever 102.8 Fahrenheit; Chest pain in the middle of sternum radiating out; Chills; Could not get out of bed; No appetite; Severe Headache; Body hurt when you touch the skin; At 7pm developed a headache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), CHEST PAIN (Chest pain in the middle of sternum radiating out), HEADACHE (At 7pm developed a headache), CHILLS (Chills) and FATIGUE (Could not get out of bed) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (At 7pm developed a headache). On 07-May-2021, the patient experienced DECREASED APPETITE (No appetite), CHILLS (Chills), FATIGUE (Could not get out of bed), HEADACHE (Severe Headache) and MYALGIA (Body hurt when you touch the skin). On 08-May-2021, the patient experienced CHEST PAIN (Chest pain in the middle of sternum radiating out) and PYREXIA (Developed a fever 102.8 Fahrenheit). On 10-May-2021, the patient experienced PYREXIA (Developed another Fever of 100.9 Fahrenheit). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 milligram and IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 200 milligram. On 07-May-2021, HEADACHE (At 7pm developed a headache) had resolved. On 09-May-2021, CHEST PAIN (Chest pain in the middle of sternum radiating out) and PYREXIA (Developed a fever 102.8 Fahrenheit) had resolved. At the time of the report, DECREASED APPETITE (No appetite), CHILLS (Chills), FATIGUE (Could not get out of bed), PYREXIA (Developed another Fever of 100.9 Fahrenheit), HEADACHE (Severe Headache) and MYALGIA (Body hurt when you touch the skin) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-118157 (Patient Link).
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dysphonia, Myalgia
Clinical narrative: cough; hoarseness; right ankle is sore; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DYSPHONIA (hoarseness) and MYALGIA (right ankle is sore) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20 and 029SLOA) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included AMLODIPINE and HYDROCHLOROTHIAZIDE for Hypertension.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced COUGH (cough), DYSPHONIA (hoarseness) and MYALGIA (right ankle is sore). The patient was treated with GUAIFENESIN (MUCINEX) at a dose of 1 dosage form. At the time of the report, COUGH (cough), DYSPHONIA (hoarseness) and MYALGIA (right ankle is sore) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was treated with  cough drops and tea with lemon.  Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jun-2021: Followup received on 13-Jun-2021 contains no new Information.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Felt achy; This spontaneous case was reported by a nurse and describes the occurrence of MYALGIA (Felt achy) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced MYALGIA (Felt achy). At the time of the report, MYALGIA (Felt achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant Product information was not provided. Treatment Information was not provided.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Sluggishness
Clinical narrative: FEELS SLUGGISH; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (FEELS SLUGGISH) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced SLUGGISHNESS (FEELS SLUGGISH). At the time of the report, SLUGGISHNESS (FEELS SLUGGISH) outcome was unknown. Unknown          Patient stated that he felt sluggishness after the second dose of vaccination  Concomitant product information, if any, was not provided by the reporter. Treatment information, if any, was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Joint swelling, Myalgia, Pain, Pyrexia
Clinical narrative: Headache; temperature; muscle aches, muscle aches throughout body; moderna rash on arm; shoulders swollen; Hurting; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (temperature), MYALGIA (muscle aches, muscle aches throughout body), VACCINATION SITE RASH (moderna rash on arm) and JOINT SWELLING (shoulders swollen) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tachycardia. Concurrent medical conditions included Rheumatoid arthritis since February 2021.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced HEADACHE (Headache), PYREXIA (temperature), MYALGIA (muscle aches, muscle aches throughout body), VACCINATION SITE RASH (moderna rash on arm), JOINT SWELLING (shoulders swollen) and PAIN (Hurting). At the time of the report, HEADACHE (Headache), PYREXIA (temperature), MYALGIA (muscle aches, muscle aches throughout body), VACCINATION SITE RASH (moderna rash on arm), JOINT SWELLING (shoulders swollen) and PAIN (Hurting) outcome was unknown. Not Provided          Lab test done included FED rate 0.2 and CRP rate 15, and dis Rheumatoid scan with an IGA reported as 69. Treatment given included Meloxicam and Gabapentin.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Headache; temperature; muscle aches, muscle aches throughout body; moderna rash on arm; shoulders swollen; Hurting; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (temperature), MYALGIA (muscle aches, muscle aches throughout body), VACCINATION SITE RASH (moderna rash on arm) and JOINT SWELLING (shoulders swollen) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tachycardia. Concurrent medical conditions included Rheumatoid arthritis since February 2021.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced HEADACHE (Headache), PYREXIA (temperature), MYALGIA (muscle aches, muscle aches throughout body), VACCINATION SITE RASH (moderna rash on arm), JOINT SWELLING (shoulders swollen) and PAIN (Hurting). At the time of the report, HEADACHE (Headache), PYREXIA (temperature), MYALGIA (muscle aches, muscle aches throughout body), VACCINATION SITE RASH (moderna rash on arm), JOINT SWELLING (shoulders swollen) and PAIN (Hurting) outcome was unknown. Not Provided          Lab test done included FED rate 0.2 and CRP rate 15, and dis Rheumatoid scan with an IGA reported as 69. Treatment given included Meloxicam and Gabapentin.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity, Paraesthesia, Pruritus
Clinical narrative: Itchy in left arm; Prickly feeling in left arm; Minor arm pain in left arm; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy in left arm), PARAESTHESIA (Prickly feeling in left arm), PAIN IN EXTREMITY (Minor arm pain in left arm) and INJECTION SITE PAIN (Pain at injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 006B21A) for COVID-19 vaccination.     Concomitant products included ATENOLOL for Blood pressure high.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced PRURITUS (Itchy in left arm), PARAESTHESIA (Prickly feeling in left arm), PAIN IN EXTREMITY (Minor arm pain in left arm) and INJECTION SITE PAIN (Pain at injection site). On 06-May-2021, PRURITUS (Itchy in left arm), PARAESTHESIA (Prickly feeling in left arm), PAIN IN EXTREMITY (Minor arm pain in left arm) and INJECTION SITE PAIN (Pain at injection site) had resolved.            Treatment details included that patient used cool and warm packs on their left arm and used witch hazel to clean the injection site.   This case was linked to US-MODERNATX, INC.-MOD-2021-123077 (E2B Linked Report). This case was linked to MOD-2021-065563 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow-up received on 17-May-2021 contains no new information regarding the case. Patient would be preferred to be contacted via telephone only and does not want any email correspondence. On 16-Jun-2021: Follow-up received on 16-Jun-2021 included patient city name. Patient doesn't wanted to provide her email address and preferred to contact verbally through phone.; Sender's Comments:  INC.-MOD-2021-123077:
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose is past 36 day mark; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is past 36 day mark) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is past 36 day mark). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is past 36 day mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is past 36 day mark) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is past 36 day mark). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is past 36 day mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-May-2021 and was forwarded to Moderna on 11-May-2021.  On an unknown date, post vaccination, the patient reported that she is 36 days late on her 2nd dose of the COVID-19.   No treatment information was provided
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for COVID 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID 19) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced COVID-19 (tested positive for COVID 19). At the time of the report, COVID-19 (tested positive for COVID 19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-May-2021, SARS-CoV-2 test: positive (Positive) tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported.   This case was linked to MOD21-089296, US-MODERNATX, INC.-MOD-2021-118513 (E2B Linked Report).; Sender's Comments:  MOD21-089296:Mother's case US-MODERNATX, INC.-MOD-2021-118513:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Gastroenteritis viral, Headache
Clinical narrative: Felt like stomach flu; Felt like a bad case of the flu; Dizziness; Headache; Fatigue; Joint pain; Nausea; Fever; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of GASTROENTERITIS VIRAL (Felt like stomach flu), INFLUENZA (Felt like a bad case of the flu), DIZZINESS (Dizziness), HEADACHE (Headache) and FATIGUE (Fatigue) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METOPROLOL for Blood pressure high, ATORVASTATIN for High cholesterol, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for an unknown indication.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced GASTROENTERITIS VIRAL (Felt like stomach flu), INFLUENZA (Felt like a bad case of the flu), DIZZINESS (Dizziness), HEADACHE (Headache), FATIGUE (Fatigue), ARTHRALGIA (Joint pain), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting). At the time of the report, GASTROENTERITIS VIRAL (Felt like stomach flu), INFLUENZA (Felt like a bad case of the flu), DIZZINESS (Dizziness), HEADACHE (Headache), FATIGUE (Fatigue), ARTHRALGIA (Joint pain), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products used included metoprolol for high blood pressure, atorvastatin for cholesterol and Prilosec.  Treatment medication included Zorfan (ondansetron) to treat with nausea.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza, Nausea, Pyrexia, Vomiting
Clinical narrative: Felt like stomach flu; Felt like a bad case of the flu; Dizziness; Headache; Fatigue; Joint pain; Nausea; Fever; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of GASTROENTERITIS VIRAL (Felt like stomach flu), INFLUENZA (Felt like a bad case of the flu), DIZZINESS (Dizziness), HEADACHE (Headache) and FATIGUE (Fatigue) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METOPROLOL for Blood pressure high, ATORVASTATIN for High cholesterol, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for an unknown indication.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced GASTROENTERITIS VIRAL (Felt like stomach flu), INFLUENZA (Felt like a bad case of the flu), DIZZINESS (Dizziness), HEADACHE (Headache), FATIGUE (Fatigue), ARTHRALGIA (Joint pain), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting). At the time of the report, GASTROENTERITIS VIRAL (Felt like stomach flu), INFLUENZA (Felt like a bad case of the flu), DIZZINESS (Dizziness), HEADACHE (Headache), FATIGUE (Fatigue), ARTHRALGIA (Joint pain), NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products used included metoprolol for high blood pressure, atorvastatin for cholesterol and Prilosec.  Treatment medication included Zorfan (ondansetron) to treat with nausea.